A detailed history of Bristlecone Advisors, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 12,427 shares of MDT stock, worth $955,387. This represents 0.1% of its overall portfolio holdings.

Number of Shares
12,427
Previous 21,026 40.9%
Holding current value
$955,387
Previous $1.73 Million 37.47%
% of portfolio
0.1%
Previous 0.18%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$82.84 - $88.09 $712,341 - $757,485
-8,599 Reduced 40.9%
12,427 $1.08 Million
Q4 2023

Jan 25, 2024

SELL
$69.43 - $83.43 $101,020 - $121,390
-1,455 Reduced 6.47%
21,026 $1.73 Million
Q3 2023

Oct 16, 2023

BUY
$78.22 - $90.4 $76,733 - $88,682
981 Added 4.56%
22,481 $1.76 Million
Q2 2023

Aug 03, 2023

SELL
$79.47 - $91.38 $76,370 - $87,816
-961 Reduced 4.28%
21,500 $1.89 Million
Q1 2023

May 11, 2023

BUY
$76.72 - $87.58 $24,857 - $28,375
324 Added 1.46%
22,461 $1.81 Million
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $132,324 - $152,404
-1,737 Reduced 7.28%
22,137 $1.72 Million
Q3 2022

Oct 27, 2022

SELL
$80.75 - $95.31 $14,212 - $16,774
-176 Reduced 0.73%
23,874 $1.93 Million
Q2 2022

Jul 25, 2022

BUY
$87.4 - $113.09 $103,743 - $134,237
1,187 Added 5.19%
24,050 $2.16 Million
Q1 2022

Apr 22, 2022

SELL
$100.58 - $112.38 $93,338 - $104,288
-928 Reduced 3.9%
22,863 $2.54 Million
Q4 2021

Jan 19, 2022

SELL
$99.53 - $127.75 $216,875 - $278,367
-2,179 Reduced 8.39%
23,791 $2.46 Million
Q3 2021

Oct 19, 2021

BUY
$122.75 - $135.17 $6,751 - $7,434
55 Added 0.21%
25,970 $3.26 Million
Q2 2021

Jul 21, 2021

SELL
$118.19 - $131.5 $46,448 - $51,679
-393 Reduced 1.49%
25,915 $3.22 Million
Q1 2021

Apr 30, 2021

SELL
$111.18 - $119.74 $537,444 - $578,823
-4,834 Reduced 15.52%
26,308 $3.11 Million
Q4 2020

Jan 25, 2021

BUY
$100.57 - $117.14 $44,552 - $51,893
443 Added 1.44%
31,142 $3.65 Million
Q3 2020

Oct 20, 2020

SELL
$90.13 - $108.78 $50,562 - $61,025
-561 Reduced 1.79%
30,699 $3.19 Million
Q2 2020

Jul 16, 2020

SELL
$84.11 - $103.33 $32,802 - $40,298
-390 Reduced 1.23%
31,260 $2.87 Million
Q1 2020

Apr 16, 2020

SELL
$72.92 - $121.3 $135,412 - $225,254
-1,857 Reduced 5.54%
31,650 $2.85 Million
Q4 2019

Jan 21, 2020

BUY
$104.49 - $114.54 $226,429 - $248,208
2,167 Added 6.91%
33,507 $3.8 Million
Q3 2019

Oct 28, 2019

SELL
$98.02 - $111.18 $94,785 - $107,511
-967 Reduced 2.99%
31,340 $3.4 Million
Q2 2019

Jul 19, 2019

BUY
$84.15 - $99.38 $39,382 - $46,509
468 Added 1.47%
32,307 $3.15 Million
Q1 2019

Apr 23, 2019

SELL
$82.45 - $93.79 $43,368 - $49,333
-526 Reduced 1.63%
31,839 $2.9 Million
Q4 2018

Jan 15, 2019

BUY
$85.8 - $99.49 $8,151 - $9,451
95 Added 0.29%
32,365 $2.94 Million
Q3 2018

Oct 22, 2018

BUY
$85.91 - $99.17 $1.07 Million - $1.23 Million
12,426 Added 62.62%
32,270 $3.17 Million
Q2 2018

Jul 31, 2018

SELL
$77.48 - $87.83 $113,508 - $128,670
-1,465 Reduced 6.88%
19,844 $1.7 Million
Q1 2018

Apr 24, 2018

SELL
$76.55 - $87.26 $354,885 - $404,537
-4,636 Reduced 17.87%
21,309 $1.71 Million
Q4 2017

Jan 30, 2018

BUY
$76.93 - $83.5 $269,639 - $292,667
3,505 Added 15.62%
25,945 $2.1 Million
Q3 2017

Oct 20, 2017

BUY
$77.71 - $84.6 $1.74 Million - $1.9 Million
22,440
22,440 $1.75 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $102B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Bristlecone Advisors, LLC Portfolio

Follow Bristlecone Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.